Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 4
1974 2
1975 1
1976 3
1977 2
1978 6
1979 13
1980 6
1981 1
1982 3
1983 13
1984 4
1985 12
1986 39
1987 9
1988 14
1989 16
1990 14
1991 26
1992 14
1993 29
1994 17
1995 14
1996 41
1997 15
1998 29
1999 28
2000 27
2001 10
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

413 results
Results by year
Filters applied: . Clear all
Page 1
Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient.
Ray JG, Burows RF, Ginsberg JS, Burrows EA. Ray JG, et al. Haemostasis. 2000 May-Jun;30(3):103-17. doi: 10.1159/000022532. Haemostasis. 2000. PMID: 11014960 Review.
The rates of venous thrombosis varied considerably, but were reported to affect 14.4% of all individuals [95% confidence interval (CI) 7.6-25.5]. ...CONCLUSION: In accordance with the apparently high rate of venous thrombosis among pregnant and nonpregnant individua …
The rates of venous thrombosis varied considerably, but were reported to affect 14.4% of all individuals [95% confidence interval (CI …
Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease.
Wehmeier A, Scharf RE, Fricke S, Schneider W. Wehmeier A, et al. Haemostasis. 1989;19(5):251-9. doi: 10.1159/000215980. Haemostasis. 1989. PMID: 2777137
Bleeding and thrombosis are a major cause of morbidity and mortality in myeloproliferative disorders (MPD). This study evaluates the relation between thrombohemorrhagic complications and platelet abnormalities in different subgroups of MPD. ...Our results indicate that pla …
Bleeding and thrombosis are a major cause of morbidity and mortality in myeloproliferative disorders (MPD). This study evaluates the …
Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.
Lechner K, Pabinger-Fasching I. Lechner K, et al. Haemostasis. 1985;15(4):254-62. doi: 10.1159/000215157. Haemostasis. 1985. PMID: 3930350
From the combined data it is concluded that the prevalence of thrombosis in patients with LA is about 30%, the thrombosis sites are the leg veins in about 66%, the cerebral arteries in 25% and the peripheral arteries in 10% of the patients. ...Heparin and oral antic …
From the combined data it is concluded that the prevalence of thrombosis in patients with LA is about 30%, the thrombosis site …
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
Hirsh J. Hirsh J. Haemostasis. 1996 Oct;26 Suppl 4:189-98. doi: 10.1159/000217298. Haemostasis. 1996. PMID: 8979124 Review.

LMWH has been compared with unfractionated heparin in the treatment of venous thrombosis. The results of a pooled analysis studies of hospitalized patients showed a significant reduction of thrombus size, p < 0.001 and in the incidence of recurrent venous thromboembolis

LMWH has been compared with unfractionated heparin in the treatment of venous thrombosis. The results of a pooled analysis studies of …
Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.
Schumacher WA, Heran CL, Youssef S, Megill JR, Michel I, Durham SK. Schumacher WA, et al. Haemostasis. 1993 Jul-Aug;23(4):219-28. doi: 10.1159/000216878. Haemostasis. 1993. PMID: 8314172
These treatments also reduced the incidence of occlusion and improved carotid blood flow during thrombosis. In contrast, aspirin alone (1 and 10 mg/kg) and the lower heparin dose (50 U/kg) did not significantly affect thrombus weight or carotid blood flow. ...These experim …
These treatments also reduced the incidence of occlusion and improved carotid blood flow during thrombosis. In contrast, aspirin alon …
Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
Krupinski K, Breddin HK. Krupinski K, et al. Haemostasis. 1991;21 Suppl 1:88-92. doi: 10.1159/000216267. Haemostasis. 1991. PMID: 1894199
Two recombinant hirudins (r-hirudin), natural hirudin and hirudin in combination with heparin or acetylsalicylic acid (ASA) have been studied in a thrombosis model in which rat mesenteric venules of a diameter of 20-30 microns were injured by well-defined argon laser lesio …
Two recombinant hirudins (r-hirudin), natural hirudin and hirudin in combination with heparin or acetylsalicylic acid (ASA) have been studie …
Past, present and future of hirudin.
Markwardt F. Markwardt F. Haemostasis. 1991;21 Suppl 1:11-26. doi: 10.1159/000216258. Haemostasis. 1991. PMID: 1894186 Review.
The efficacy of hirudin in preventing venous and arterial thrombosis and disseminated intravascular coagulation was demonstrated in various animal models. ...
The efficacy of hirudin in preventing venous and arterial thrombosis and disseminated intravascular coagulation was demonstrated in v …
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL. Gemmati D, et al. Haemostasis. 2001 Mar-Apr;31(2):99-105. doi: 10.1159/000048050. Haemostasis. 2001. PMID: 11684865 Free article.
We report a thrombosis-prone family in which one subject--the propositus who exhibited combined heterozygous FV G1691A and FII G20210A mutations--showed spontaneous and early clinical onset (at 23 years), recurrences of deep-vein thrombosis and pulmonary embolism. . …
We report a thrombosis-prone family in which one subject--the propositus who exhibited combined heterozygous FV G1691A and FII G20210 …
Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent.
Fumagalli G, Angelaccio E, Lombardo N, Clementi F. Fumagalli G, et al. Haemostasis. 1987;17(6):361-70. doi: 10.1159/000215771. Haemostasis. 1987. PMID: 3428723
Thrombosis was induced by inserting a collagen-coated thread into the femoral vein of rabbits 2 h before sacrifice. The results show that Defibrotide is highly effective in reducing the size of the thrombus. ...
Thrombosis was induced by inserting a collagen-coated thread into the femoral vein of rabbits 2 h before sacrifice. The results show
413 results
Jump to page
Feedback